PD-1	Programmed cell death protein
MHC	Major histocompatibility complex
APC	Antigen-presenting cell
TME	Tumor microenvironments
CTLA4	Cytotoxic T lymphocyte antigen 4
HIV	Human immunodeficiency virus
LRA	Latency-reversing agent
PD-L1/L2	Programmed death receptor ligand 1/ligand 2
TB	Human tuberculosis
NK cells	Natural killer cells
PBMCs	Peripheral blood mononuclear cells
LAG3	Lymphocyte activation gene 3 protein
HBV	Hepatitis B virus
HCV	Hepatitis C virus
CHB	Chronic hepatitis B infection
TIM3	T cell immunoglobulin and mucin 3
Ig	Immunoglobulin
VP	Viremic progressors
EC	Elite controller
HC	Healthy controls
Ag	Antigen
AIDS	Acquired immunodeficiency syndrome
Tfh	T follicular helper cells
SIV	Simian immunodeficiency virus
DC	Dendritic cell
TLR	Toll-like receptor
Tat	Transcriptional activator
ART	Antiretroviral therapy
HAART	Highly active antiretroviral therapy
MIP-1α	Macrophage inflammatory protein-1-alpha
MIP-1β	Macrophage inflammatory protein-1-beta
CD40L	CD40 ligand
IFNγ	Interferon-gamma
GraB cell	Granzyme B-expressing B cell
TCR	T cell receptor
Fas	First apoptosis signal receptor
TI	Therapy interruption
FDA	Food and Drug Administration
NSCLC	Non-small cell lung cancer